FIELD: pharmaceutics.
SUBSTANCE: the suggested composition contains phosphatide, cholesterol, amino acids and lyophilized excipient. The composition mentioned contains no polyoxyethylated castor oil and deals with substitution of toxic expensive adjuvant with nontoxic medium and easily obtained adjuvant and could be adapted for industrial manufacturing. The method for obtaining the above-mentioned composition deals with mixing the above-mentioned components, drying and sterilization. Innovation provides low toxicity, good tolerance by a patient, high solubility in water and increased stability due to no aggregation and fall out of crystals.
EFFECT: higher efficiency of application.
13 cl, 14 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMAL COMPOSITION AND METHOD OF ITS PREPARATION | 2012 |
|
RU2514000C1 |
| LIPOSOMAL COMPOSITION AND METHOD FOR PRODUCTION THEREOF | 2012 |
|
RU2516893C1 |
| TUMOUR TREATMENT AGENT AND KIT CONTAINING LIPOSOMAL GEMCITABINE COMPOSITION | 2016 |
|
RU2761620C2 |
| AGENT FOR TREATING A TUMOR AND A KIT CONTAINING A LIPOSOMAL COMPOSITION OF GEMCITABINE | 2016 |
|
RU2738365C2 |
| LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
| AGENT FOR TREATING TUMOUR AND KIT CONTAINING LIPOSOMAL COMPOSITION OF GEMCITABINE | 2016 |
|
RU2768178C2 |
| METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
| METHOD OF PRODUCING LIPOSOMAL COSMETIC SERUM IN DRY LYOPHILIZED FORM FOR FACE, NECK AND CLEAVAGE SKIN CARE | 2023 |
|
RU2825130C1 |
| ANTHELMINTHIC AGENT | 1998 |
|
RU2153329C2 |
| ERYTHROPOIETIN LIPOSOMAL DISPERSION | 1999 |
|
RU2218914C2 |
